Actively Recruiting
A Randomized Controlled Study of Online Outpatient Follow-up in Patients With Papillary Thyroid Cancer After Surgery
Led by West China Hospital · Updated on 2025-01-30
388
Participants Needed
1
Research Sites
8 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the use of online outpatient follow-up compared to traditional offline follow-up for patients who have undergone surgery for papillary thyroid cancer. This randomized controlled trial aims to assess the adherence to outpatient procedures over a 12-month period. The study includes adults between 18 and 90 years old who have had thyroid surgery and are able to communicate in Chinese and use the internet for visits. Participants are randomly assigned to one of two groups: one group uses the Huayitong app for their post-operative follow-up, while the other group attends standard in-person outpatient clinics. The study will monitor participants through three follow-up visits at 1, 3, and 6 months after surgery. Participants assigned to online visits may switch to offline visits or withdraw from the trial if technical issues arise or additional medical care is needed. During the study, investigators collect demographic and medical information, details of symptoms and treatment, patient satisfaction, and other relevant data through questionnaires and electronic medical records. Safety is monitored through a review of medical records and participant surveys 30 days after the final follow-up. The main outcome measured is adherence to outpatient procedures, with secondary outcomes including general quality of life.
CONDITIONS
Brief Title
A Study of Online Follow-up in Patients With Papillary Thyroid Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinical diagnosis of papillary thyroid cancer
- Has undergone thyroid surgery (including endoscopic and open surgery)
- Between 18 and 90 years of age
- Speaks Chinese
- Able to use mobile phones and the internet to complete visits
- Voluntarily agrees to participate and signs informed consent
You will not qualify if you...
- Postoperative hospital stay longer than 5 days
- Unable to complete online visits due to no device or internet access
- High risk of postoperative complications such as recurrent laryngeal nerve injury
- Unable to participate due to other medical conditions, lab results, or physical disability
- Pregnant
- Has mental illness or takes psychotropic drugs and was not able to perform surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 months
Participants receive follow-up care after thyroid surgery either through the Huayitong APP or traditional outpatient clinics.
Regular follow-up visits either online or offline over 12 months
Trial Site Locations
Total: 1 location
1
West China Hospital
Chengdu, Sichuan, China, 610041
Actively Recruiting
Research Team
J
Jianyong Lei, Md
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here